AngioDynamics News

AngioDynamics Analyst Ratings

BenzingaApr 5 20:39

AngioDynamics Stock Upgraded by Oppenheimer on FDA Approval, Strong Balance Sheet

InvestingApr 5 20:16

Buy Rating Reaffirmed for AngioDynamics Amidst Strategic Growth and Med-Tech Sector Potential

TipRanksApr 5 18:56

Analysts' Top Healthcare Picks: AngioDynamics (ANGO), Corcept Therapeutics (CORT)

TipRanksFeb 16 19:20

Raymond James Maintains Outperform on AngioDynamics, Lowers Price Target to $10

BenzingaJan 9 18:07

AngioDynamics Analyst Ratings

BenzingaJan 9 18:06

Oppenheimer Keeps Their Hold Rating on AngioDynamics (ANGO)

TipRanksJan 8 20:55

HC Wainwright & Co. Maintains Buy on AngioDynamics, Lowers Price Target to $18

BenzingaJan 8 19:33

AngioDynamics Analyst Ratings

BenzingaJan 8 19:32

Buy Rating Maintained for AngioDynamics Amidst Strategic Restructuring and New Product Launches

TipRanksJan 8 19:26

Raymond James Maintains Outperform on AngioDynamics, Lowers Price Target to $12

BenzingaOct 6, 2023 16:16

AngioDynamics Analyst Ratings

BenzingaOct 6, 2023 02:29

HC Wainwright & Co. Maintains Buy on AngioDynamics, Raises Price Target to $20

BenzingaOct 5, 2023 19:12

AngioDynamics Analyst Ratings

BenzingaOct 5, 2023 19:11

Analysts Have Conflicting Sentiments on These Healthcare Companies: AngioDynamics (ANGO), Ionis Pharmaceuticals (IONS) and Akero Therapeutics (AKRO)

TipRanksOct 5, 2023 18:31

Analysts Offer Insights on Healthcare Companies: AngioDynamics (ANGO), Enlivex (ENLV) and Relmada Therapeutics (RLMD)

TipRanksSep 25, 2023 18:20

HC Wainwright & Co. Initiates Coverage On AngioDynamics With Buy Rating, Announces Price Target of $19

BenzingaSep 25, 2023 18:14

AngioDynamics Analyst Ratings

BenzingaSep 25, 2023 18:13

Canaccord Genuity Maintains Buy on AngioDynamics, Raises Price Target to $20

BenzingaJul 13, 2023 22:53

AngioDynamics Analyst Ratings

BenzingaJul 13, 2023 22:52